Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03721367 · ClinicalTrials.gov registry record
Chronic Liver Disease in Urea Cycle Disorders
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 28
- Enrollment target
NCT03721367 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 28 participants.
The verdict
NCT03721367 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
This is a pilot, cross-sectional study to assess liver stiffness and markers of hepatic injury, function, and fibrosis in patients with urea cycle disorders. This study will be conducted at 3 UCDC sites: Baylor College of Medicine in Houston, Texas, University of California San Francisco (UCSF), San Francisco, California and Seattle Children's Hospital, Seattle,Washington
Interventions
- OTHER Diagnostic Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-11-29 |
| Est. Completion | 2020-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03721367
The ClinicalTrials.gov registry entry for NCT03721367 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diagnostic Ultrasound is the first listed.
NCT03721367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03721367 about?
NCT03721367 is a clinical study titled "Chronic Liver Disease in Urea Cycle Disorders". This is a pilot, cross-sectional study to assess liver stiffness and markers of hepatic injury, function, and fibrosis in patients with urea cycle disorders. This study will be conducted at 3 UCDC sites: Baylor College of Medicine in Houston, Texas, University of California San Francisco (UCSF), San...
What is the current status of trial NCT03721367?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2017-11-29. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03721367?
The interventions under investigation include: Diagnostic Ultrasound (OTHER).
Who is sponsoring clinical trial NCT03721367?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.